Bleximenib oxalate(2866179-95-3)
- Name: Bleximenib oxalate
- Synonyms:Bleximenib oxalate;(R)-N-Ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide oxalate;Benzamide, N-ethyl-5-fluoro-2-[[5-[2-[(1R)-4-[(2-methoxyethyl)methylamino]-1-(1-methylethyl)butyl]-2,6-diazaspiro[3.4]oct-6-yl]-1,2,4-triazin-6-yl]oxy]-N-(1-methylethyl)-, ethanedioate (1:1);Bleximenib
- Molecular Formula:C32H50FN7O3.C2H2O4
- Molecular Weight:689.82
- CAS Registry Number:2866179-95-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 2865127-17-7/(S)-3-(5-bromo-1-ethyl-2-(2-(1-methoxyethyl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropyl acetate
- 2865128-07-8/15H-3,5-Etheno-14,18-imino-6,10-methano-6H-pyrrolo[3,4-g][1,12,4,18]dioxadiazacyclodocosine-13,19(10H,16H)-dione, 12-amino-1-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-2,7,8,11,12,17,18,21,22,23-decahydro-22,22-dimethyl-2-(2,2,2-trifluoroethyl)-, (10S,12S,18S)-
- 2865161-71-1/Indobufen Impurity 31
- 2865162-09-8/benzyl (S)-4-(5-(5-bromo-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-1H-indol-2-yl)-6-(1-methoxyethyl)pyridin-3-yl)piperazine-1-carboxylate
- 2865162-10-1/benzyl (S)-4-(5-(1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indol-2-yl)-6-(1-methoxyethyl)pyridin-3-yl)piperazine-1-carboxylate
- 2865162-12-3/methyl (S)-1-((S)-3-(4-(2-(5-(4-((benzyloxy)carbonyl)piperazin-1-yl)-2-((S)-1-methoxyethyl)pyridin-3-yl)-1-ethyl-3-(3-hydroxy-2,2-dimethylpropyl)-
- 2865162-15-6/(S)-3-(5-bromo-2-(2-(1-methoxyethyl)pyridin-3-yl)-1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)-2,2-dimethylpropan-1-ol
- 2865208-89-3/Pyrazolo[1,5-a]pyrimidin-7-amine, 3-bromo-5,6-dichloro-
- 28654-22-0/2-Propenoic acid, 2-methyl-, polymer with dodecyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate
- 2865838-89-5/3-Pyridazinecarboxylic acid, hexahydro-, methyl ester, hydrochloride (1:2), (3S)-
- 2865859-71-6/3-(6-Bromo-1-oxophthalazin-2(1H)-yl)piperidine-2,6-dione
- 2865889-34-3/Dibenzofuran-1,2,3,4,6,7,8-d7, 9-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
- 2865897-68-1/3-Pyridinecarboxylic acid, 2-(2-hydroxyethyl)-
- 2865897-80-7/3-Pyridinecarboxylic acid, 2-(2-hydroxyethyl)-, phenylmethyl ester
- 2865897-85-2/3-Pyridinecarboxylic acid, 2-[2-(acetyloxy)ethyl]-, phenylmethyl ester
- 2865897-86-3/2-[2-(acetyloxy)ethyl]pyridine-3-carboxylic acid
- 2866128-07-4/(4-(2-methoxyethoxy)phenyl)diphenylphosphane
- 2866128-08-5/(4-(2-(2-methoxyethoxy)ethoxy)phenyl)diphenylphosphane
- 2866174-39-0/Pyridine, 2,6-bis[(4S)-4,5-dihydro-4-methyl-2-oxazolyl]-4-(trifluoromethyl)-
- 2866179-95-3/Bleximenib oxalate
- 28662-50-2/6-Chloro-4-methylquinoline-8-carboxylic acid
- 2866301-96-2/Fmoc-Gly-Gly-Phe-Gly-NH-CH2-O-CO-CH3
- 2866302-04-5/(S)-11-Benzyl-1-(9H-fluoren-9-YL)-3,6,9,12,15-pentaoxo-2-oxa-4,7,10,13,16-pentaazaoctadecan-18-oic acid
- 2866307-17-5/Methyl 2-bromo-1H-imidazole-5-carboxylate (hydrochloride)
- 2866314-76-1/2-(2-cyclopropylpyridin-3-yl)-4-fluorophenol
- 2866352-08-9/2-Pyridinamine, 3-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
- 2866415-92-9/NA
- 2866415-98-5/BMS-986165(Deucravacitinib)
- 2866429-93-6/Biotin-PEG3-SS-azide
- 28669-74-1/Pyrido[2,3-d]pyrimidin-5(8H)-one, 2-methyl-
